Sildenafil Citrate Tablets 25mg (Viagra® / バイアグラ錠25mg)

JPY ¥15,700

Japanese Erectile Dysfunction Treatment Agent (Sildenafil Citrate 25mg). Oral tablet taken once daily approximately 1 hour before sexual activity. 20 tablets [10 tablets (PTP) x 2]. Mfd. by Viatris Pharmaceuticals LLC, Japan.

Bulk deal
Quantity Discount Discounted price
5 - 9 8% JPY ¥14,444
10 - 19 12% JPY ¥13,816
20 + 18% JPY ¥12,874
SKU: VIA-25-TAB Category:

Description

Product Overview / 商品概要

Viagra Tablets 25mg (バイアグラ錠25mg)
Generic: Sildenafil Citrate / シルデナフィルクエン酸塩
Therapeutic Category: Erectile Dysfunction Treatment Agent / 勃起不全治療剤
Manufactured by: Viatris Pharmaceuticals LLC / ヴィアトリス製薬合同会社

Composition & Specification / 組成・規格

Active Ingredient: Sildenafil Citrate 35.12mg (as Sildenafil 25mg) per tablet / 1錠中 シルデナフィルクエン酸塩35.12mg(シルデナフィルとして25mg)
Additives: Microcrystalline cellulose, Anhydrous dibasic calcium phosphate, Croscarmellose sodium, Magnesium stearate, Hypromellose, Lactose hydrate, Titanium dioxide, Triacetin, FD&C Blue No. 2 / 結晶セルロース、無水リン酸水素カルシウム、クロスカルメロースナトリウム、ステアリン酸マグネシウム、ヒプロメロース、乳糖水和物、酸化チタン、トリアセチン、青色2号
Appearance: Blue film-coated tablet, identification code: VIAGRA VGR 25
外観: 青色フィルムコート錠、識別コード: VIAGRA VGR 25

Indications / 効能効果

EN: Erectile dysfunction (patients unable to achieve or maintain an erection sufficient for satisfactory sexual intercourse)
JA: 勃起不全(満足な性行為を行うに十分な勃起とその維持が出来ない患者)

Dosage and Administration / 用法用量

EN: Usually, adults take 25mg to 50mg (as sildenafil) orally once daily, approximately 1 hour before sexual activity. For elderly patients (65 years and older), patients with hepatic impairment, and patients with severe renal impairment (Ccr <30 mL/min), the starting dose should be 25mg due to increased plasma concentrations. Dosing is limited to once daily with an interval of at least 24 hours.
JA: 通常、成人には1日1回シルデナフィルとして25mg~50mgを性行為の約1時間前に経口投与する。高齢者(65歳以上)、肝障害のある患者及び重度の腎障害(Ccr<30mL/min)のある患者については、本剤の血漿中濃度が増加することが認められているので、25mgを開始用量とすること。1日の投与は1回とし、投与間隔は24時間以上とすること。

Contraindications / 禁忌

EN: Patients with a history of hypersensitivity to any component of this product / Patients receiving nitrates or nitric oxide (NO) donors (nitroglycerin, amyl nitrite, isosorbide nitrate, nicorandil, etc.) / Patients for whom sexual activity is inadvisable due to cardiovascular disorders / Patients with severe hepatic impairment / Patients with hypotension (BP 170 mmHg or resting diastolic BP >100 mmHg) / Patients with a history of cerebral infarction, cerebral hemorrhage, or myocardial infarction within the past 6 months / Patients with retinitis pigmentosa / Patients receiving amiodarone hydrochloride (oral) / Patients receiving soluble guanylate cyclase (sGC) stimulators (riociguat)
JA: 本剤の成分に対し過敏症の既往歴のある患者/硝酸剤あるいは一酸化窒素(NO)供与剤(ニトログリセリン、亜硝酸アミル、硝酸イソソルビド、ニコランジル等)を投与中の患者/心血管系障害を有するなど性行為が不適当と考えられる患者/重度の肝機能障害のある患者/低血圧の患者(血圧<90/50mmHg)又は治療による管理がなされていない高血圧の患者(安静時収縮期血圧>170mmHg又は安静時拡張期血圧>100mmHg)/脳梗塞・脳出血や心筋梗塞の既往歴が最近6ヵ月以内にある患者/網膜色素変性症患者/アミオダロン塩酸塩(経口剤)を投与中の患者/可溶性グアニル酸シクラーゼ(sGC)刺激剤(リオシグアト)を投与中の患者

Regulatory Information / 規制情報

Approval No.: 21100AMZ00053
Sales Started: March 1999 / 1999年3月
Classification Code: 872599
Storage: Store at room temperature / 室温保存
Shelf Life: 5 years / 5年

Packaging / 包装

Main Package (for sale): 20 tablets [10 tablets (PTP) x 2] / 20錠[10錠(PTP)×2]
Other Available Packages (by special order): Insurance-covered: 20 tablets [10 tablets (PTP) x 2] / Non-NHI listed: 20 tablets [10 tablets (PTP) x 2]

Full product insert (添付文書) is attached as a downloadable PDF. For detailed precautions, drug interactions, and safety information, please refer to the official package insert.

Additional information

重さ 0.15 kg

Reviews

There are no reviews yet.

Be the first to review “Sildenafil Citrate Tablets 25mg (Viagra® / バイアグラ錠25mg)”

メールアドレスが公開されることはありません。 ※ が付いている欄は必須項目です

Export from Japan — Sildenafil Citrate Tablets 25mg (Viagra®

🏭 Supply & Origin

  • Country of Origin: Japan
  • Regulatory Standard: PMDA (Japan) / GMP Compliant
  • Pharmacopoeia: Japanese Pharmacopoeia (JP)
  • Supplier: Mate Co., Ltd. — Licensed Pharmaceutical Wholesaler (License No. B14309, Osaka)
  • Supply Capacity: Full-line sourcing through Japan's regulated distribution channels

🚚 Shipping & Trade Terms

  • Incoterms: FOB Kansai International Airport (KIX)
  • Shipping: Air freight via B/L or AWB
  • Payment: 100% T/T in advance
  • Lead Time: 2-4 weeks after payment confirmation
  • Available Regions: EU, LATAM, APAC, Middle East, Africa

Request a Quotation

For pricing, MOQ, and regulatory documentation, contact our export team:

Email: kurimoto@mate-osaka.co.jp
Tel: +81-72-665-5736

All exports are conducted through proper regulatory procedures including customs clearance, B/L or AWB documentation, and T/T advance payment. We do not engage in hand-carry, cash transactions, or sales to unlicensed parties.